122 related articles for article (PubMed ID: 38355353)
21. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.
Liu Z; Yang Z; Li J; Liu Z; Ma N; Chen P; Bi X; Li Z; Dong P; Han H; He X; Mao X; Guo S
Asian J Surg; 2023 Sep; 46(9):3607-3613. PubMed ID: 37147255
[TBL] [Abstract][Full Text] [Related]
22. Predictors of postoperative recurrence in patients with non-metastatic pT3a renal cell carcinoma.
Ohsugi H; Ohe C; Yoshida T; Ikeda J; Sugi M; Kinoshita H; Matsuda T
Int J Urol; 2021 Oct; 28(10):1060-1066. PubMed ID: 34346110
[TBL] [Abstract][Full Text] [Related]
23. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
Leibovich BC; Cheville JC; Lohse CM; Zincke H; Kwon ED; Frank I; Thompson RH; Blute ML
J Urol; 2005 Mar; 173(3):716-9. PubMed ID: 15711250
[TBL] [Abstract][Full Text] [Related]
24. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
[TBL] [Abstract][Full Text] [Related]
25. To stage or not to stage: determining the true clinical significance of the biopsy tract through perinephric fat in assessing renal cell carcinoma.
Valencia-Guerrero A; Oliva E; Wu CL; Wu S; Rice-Stitt T; Sadow PM; Dahl DM; Feldman AS; Arellano RS; Cornejo KM
Histopathology; 2021 Jun; 78(7):951-962. PubMed ID: 33236381
[TBL] [Abstract][Full Text] [Related]
26. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
27. Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma.
Poon SA; Gonzalez JR; Benson MC; McKiernan JM
BJU Int; 2009 Jun; 103(12):1622-5. PubMed ID: 19154464
[TBL] [Abstract][Full Text] [Related]
28. Significance of tumor size in renal cell cancer with perinephric fat infiltration: is TNM staging system adequate for predicting prognosis?
Süer E; Baltaci S; Burgu B; Aydoğdu Ö; Göğüş Ç
Urol J; 2013; 10(1):774-9. PubMed ID: 23504681
[TBL] [Abstract][Full Text] [Related]
29. Multiple Patterns of Perirenal Fat Invasion Are Associated With a Poorer Prognosis Compared With Isolated Invasion: A Proposal for a Revision of T3aN0M0 TNM Staging System.
Wang Z; Yu K; Zhu Y; Feng C; Liu C; Liu S; Wang J; Zeng X
Front Oncol; 2020; 10():336. PubMed ID: 32219068
[No Abstract] [Full Text] [Related]
30. Prognostic Evaluation of the Site of Invasion in Pathological Stage T3a Renal Cell Carcinoma.
Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Hung SC; Cheng CL; Ou YC; Chiu KY
In Vivo; 2021; 35(2):1083-1089. PubMed ID: 33622905
[TBL] [Abstract][Full Text] [Related]
31. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
33. Stage T3a renal cell carcinoma: staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion.
Sokhi HK; Mok WY; Patel U
Br J Radiol; 2015 Jan; 88(1045):20140504. PubMed ID: 25410425
[TBL] [Abstract][Full Text] [Related]
34. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
35. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma.
Siddiqui SA; Frank I; Leibovich BC; Cheville JC; Lohse CM; Zincke H; Blute ML
J Urol; 2007 Jan; 177(1):59-62. PubMed ID: 17162000
[TBL] [Abstract][Full Text] [Related]
36. Oncologic outcomes and predictive factors for progression in pT3a renal cell carcinoma.
Culpan M; Iplikci A; Kazan HO; Atis G; Yildirim A
Arch Esp Urol; 2022 May; 75(4):310-317. PubMed ID: 35818910
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of subclassifying stage pT3a renal tumors with fat invasion: a retrospective study of 99 patients.
Xu X; Zhu D
J Int Med Res; 2021 Aug; 49(8):3000605211033178. PubMed ID: 34382464
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of the site of invasion in T3aN0M0 clear cell renal cell carcinoma.
Guo S; Liu Z; Li X; Yao K; Dong P; Chen D; Liao C; Long Z; Wang Y; Zhou F; He X; Liu Z
Urol Oncol; 2019 May; 37(5):301.e11-301.e17. PubMed ID: 30704960
[TBL] [Abstract][Full Text] [Related]
39. ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy.
Park JS; Kim H; Jang WS; Kim J; Ham WS; Lee ST
Cancer Sci; 2024 May; 115(5):1680-1687. PubMed ID: 38475661
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
